View clinical trials related to Acne Vulgaris.
Filter by:In this multicenter study, patients with dark skin and acne vulgaris will be included. The patients will receive treatment with MAL PDT and placebo PDT.
This study is to determine the efficacy and safety of 12 week treatment with Differin® Gel 0.3% applied in the evening, in combination with Duac® (Clindamycin/Benzoyl Peroxide Gel) applied in the morning, in Subjects with Acne vulgaris.
The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Phase 4 commitment pharmacokinetic study to determine systemic exposure to adapalene.
The purpose of this research study is to see how often benzoyl peroxide is applied for acne. Use of medication was monitored electronically.
The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris during 6 treatment cycles
The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris during 6 treatment cycles.
Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.